Radioimmunotherapy
This graph shows the total number of publications written about "Radioimmunotherapy" by people in the URMC Research Network by year, and whether "Radioimmunotherapy" was a major or minor topic of these publication.
Below are the most recent publications written about "Radioimmunotherapy" by people in Profiles.
-
Rosenblat TL, McDevitt MR, Mulford DA, Pandit-Taskar N, Divgi CR, Panageas KS, Heaney ML, Chanel S, Morgenstern A, Sgouros G, Larson SM, Scheinberg DA, Jurcic JG. Sequential cytarabine and alpha-particle immunotherapy with bismuth-213-lintuzumab (HuM195) for acute myeloid leukemia. Clin Cancer Res. 2010 Nov 1; 16(21):5303-11.
-
Bernstein SH, Burack WR. The incidence, natural history, biology, and treatment of transformed lymphomas. Hematology Am Soc Hematol Educ Program. 2009; 532-41.
-
Link BK, Friedberg JW. Monoclonal antibodies in lymphoma: the first decade. Semin Hematol. 2008 Apr; 45(2):71-4.
-
Schaefer-Cutillo J, Friedberg JW. Non-myeloablative radioimmunotherapy for non-Hodgkin's lymphoma. Semin Hematol. 2008 Apr; 45(2):110-7.
-
Friedberg JW. Secondary malignancies after therapy of indolent non-Hodgkin's lymphoma. Haematologica. 2008 Mar; 93(3):336-8.
-
Roboz GJ, Bennett JM, Coleman M, Ritchie EK, Furman RR, Rossi A, Jhaveri K, Feldman EJ, Leonard JP. Therapy-related myelodysplastic syndrome and acute myeloid leukemia following initial treatment with chemotherapy plus radioimmunotherapy for indolent non-Hodgkin lymphoma. Leuk Res. 2007 Aug; 31(8):1141-4.
-
Schaefer-Cutillo J, Friedberg JW, Fisher RI. Novel concepts in radioimmunotherapy for non-Hodgkin's lymphoma. Oncology (Williston Park). 2007 Feb; 21(2):203-12; discussion 214, 217, 221.
-
Friedberg JW. Potential long-term toxicities should influence the choice of therapy for indolent non-Hodgkin's lymphoma. Haematologica. 2006 Nov; 91(11):1453-5.
-
Press OW, Unger JM, Braziel RM, Maloney DG, Miller TP, Leblanc M, Fisher RI. Phase II trial of CHOP chemotherapy followed by tositumomab/iodine I-131 tositumomab for previously untreated follicular non-Hodgkin's lymphoma: five-year follow-up of Southwest Oncology Group Protocol S9911. J Clin Oncol. 2006 Sep 1; 24(25):4143-9.
-
Fisher RI, Coiffier B, Vose JM. Advances in the treatment of hematologic malignancies. Part 1 of a 3-part series: Aggressive lymphomas. Clin Adv Hematol Oncol. 2006 Apr; 4(4):suppl 1, 4-9; discussion suppl 10; quiz 2 p following suppl 10.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
|
